12/29/2023 0 Comments Nova stock![]() Not being fully vaccinated and boosted, if eligible Personal risk factors for severe illness include: “This is especially important for those most at risk of severe outcomes of COVID-19.” “We strongly recommend New Brunswickers stay up to date with their COVID-19 vaccines, including getting a fall or winter booster, if five months have passed since their last COVID-19 vaccine or infection, regardless of how many COVID-19 vaccine doses they have had in the past,” said Léger. People between the ages of 12 and 17 who are at higher risk of severe outcomes from COVID-19 were already eligible for the vaccine, according to the province. Starting Tuesday, residents aged 18 and over will be eligible to receive a bivalent vaccine booster. More New Brunswickers will be eligible for the COVID-19 bivalent shot beginning next week. “Vaccination remains the best way to prevent severe symptoms of COVID-19 and influenza," said Dr. ![]() In a news release Thursday, New Brunswick's acting deputy chief medical officer of health says, with weather becoming cooler and people spending more time indoors, the chances of viruses spreading will increase. Nova ( NASDAQ:NVMI - Get Rating) last issued its quarterly earnings results on Thursday, August 4th.Public Health in New Brunswick is urging residents to book their COVID-19 booster and influenza vaccines. The firm's fifty day moving average price is $99.04 and its two-hundred day moving average price is $99.37. The stock has a market capitalization of $2.34 billion, a PE ratio of 22.34, a price-to-earnings-growth ratio of 2.37 and a beta of 1.29. The company has a current ratio of 4.98, a quick ratio of 4.10 and a debt-to-equity ratio of 0.37. ![]() 68.37% of the stock is owned by hedge funds and other institutional investors. Creative Planning now owns 3,215 shares of the semiconductor company's stock valued at $285,000 after purchasing an additional 114 shares in the last quarter. Finally, Creative Planning increased its holdings in shares of Nova by 3.7% during the 2nd quarter. Thrivent Financial for Lutherans now owns 98,233 shares of the semiconductor company's stock valued at $8,696,000 after purchasing an additional 6,487 shares in the last quarter. Thrivent Financial for Lutherans increased its holdings in shares of Nova by 7.1% during the 2nd quarter. Castleview Partners LLC purchased a new position in shares of Nova during the 2nd quarter valued at approximately $62,000. ExodusPoint Capital Management LP purchased a new position in shares of Nova during the 2nd quarter valued at approximately $353,000. Amundi now owns 59,759 shares of the semiconductor company's stock valued at $5,468,000 after purchasing an additional 55,389 shares in the last quarter. Amundi increased its holdings in shares of Nova by 1,267.5% during the 2nd quarter. Hedge Funds Weigh In On NovaĪ number of institutional investors have recently bought and sold shares of the business. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $129.75. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Separately, Benchmark lowered their target price on shares of Nova from $146.00 to $140.00 in a research note on Tuesday, August 9th. The stock had previously closed at $87.33. Nova traded as low as $81.38 and last traded at $81.38, with a volume of 2236 shares changing hands. ![]() Bank of America currently has a buy rating on the stock. ( NASDAQ:NVMI - Get Rating)'s stock price reached a new 52-week low on Friday after Bank of America lowered their price target on the stock from $130.00 to $107.00.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |